<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en" dir="ltr">
	<head>
		<meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
		<meta http-equiv="Content-Style-Type" content="text/css" />
		<meta name="generator" content="MediaWiki 1.15alpha" />
		<meta name="keywords" content="Etanercept,Wikipedia articles needing clarification from February 2009,Articles with unsourced statements since June 2007,Articles with unsourced statements since January 2009,Special:Search/Etanercept,ATC code L04,Abatacept,Abetimus,Adalimumab,Afelimomab,Aflibercept" />
		<link rel="alternate" type="application/x-wiki" title="Edit this page" href="/w/index.php?title=Etanercept&amp;action=edit" />
		<link rel="edit" title="Edit this page" href="/w/index.php?title=Etanercept&amp;action=edit" />
		<link rel="apple-touch-icon" href="http://en.wikipedia.org/apple-touch-icon.png" />
		<link rel="shortcut icon" href="/favicon.ico" />
		<link rel="search" type="application/opensearchdescription+xml" href="/w/opensearch_desc.php" title="Wikipedia (en)" />
		<link rel="copyright" href="http://www.gnu.org/copyleft/fdl.html" />
		<link rel="alternate" type="application/rss+xml" title="Wikipedia RSS Feed" href="/w/index.php?title=Special:RecentChanges&amp;feed=rss" />
		<link rel="alternate" type="application/atom+xml" title="Wikipedia Atom Feed" href="/w/index.php?title=Special:RecentChanges&amp;feed=atom" />
		<title>Etanercept - Wikipedia, the free encyclopedia</title>
		<link rel="stylesheet" href="/skins-1.5/common/shared.css?207xx" type="text/css" media="screen" />
		<link rel="stylesheet" href="/skins-1.5/common/commonPrint.css?207xx" type="text/css" media="print" />
		<link rel="stylesheet" href="/skins-1.5/monobook/main.css?207xx" type="text/css" media="screen" />
		<link rel="stylesheet" href="/skins-1.5/chick/main.css?207xx" type="text/css" media="handheld" />
		<!--[if lt IE 5.5000]><link rel="stylesheet" href="/skins-1.5/monobook/IE50Fixes.css?207xx" type="text/css" media="screen" /><![endif]-->
		<!--[if IE 5.5000]><link rel="stylesheet" href="/skins-1.5/monobook/IE55Fixes.css?207xx" type="text/css" media="screen" /><![endif]-->
		<!--[if IE 6]><link rel="stylesheet" href="/skins-1.5/monobook/IE60Fixes.css?207xx" type="text/css" media="screen" /><![endif]-->
		<!--[if IE 7]><link rel="stylesheet" href="/skins-1.5/monobook/IE70Fixes.css?207xx" type="text/css" media="screen" /><![endif]-->
		<link rel="stylesheet" href="/w/index.php?title=MediaWiki:Common.css&amp;usemsgcache=yes&amp;ctype=text%2Fcss&amp;smaxage=2678400&amp;action=raw&amp;maxage=2678400" type="text/css" />
		<link rel="stylesheet" href="/w/index.php?title=MediaWiki:Print.css&amp;usemsgcache=yes&amp;ctype=text%2Fcss&amp;smaxage=2678400&amp;action=raw&amp;maxage=2678400" type="text/css" media="print" />
		<link rel="stylesheet" href="/w/index.php?title=MediaWiki:Handheld.css&amp;usemsgcache=yes&amp;ctype=text%2Fcss&amp;smaxage=2678400&amp;action=raw&amp;maxage=2678400" type="text/css" media="handheld" />
		<link rel="stylesheet" href="/w/index.php?title=MediaWiki:Monobook.css&amp;usemsgcache=yes&amp;ctype=text%2Fcss&amp;smaxage=2678400&amp;action=raw&amp;maxage=2678400" type="text/css" />
		<link rel="stylesheet" href="/w/index.php?title=-&amp;action=raw&amp;maxage=2678400&amp;gen=css" type="text/css" />
		<!--[if lt IE 7]><script type="text/javascript" src="/skins-1.5/common/IEFixes.js?207xx"></script>
		<meta http-equiv="imagetoolbar" content="no" /><![endif]-->

		<script type= "text/javascript">/*<![CDATA[*/
		var skin = "monobook";
		var stylepath = "/skins-1.5";
		var wgArticlePath = "/wiki/$1";
		var wgScriptPath = "/w";
		var wgScript = "/w/index.php";
		var wgVariantArticlePath = false;
		var wgActionPaths = {};
		var wgServer = "http://en.wikipedia.org";
		var wgCanonicalNamespace = "";
		var wgCanonicalSpecialPageName = false;
		var wgNamespaceNumber = 0;
		var wgPageName = "Etanercept";
		var wgTitle = "Etanercept";
		var wgAction = "view";
		var wgArticleId = "732438";
		var wgIsArticle = true;
		var wgUserName = null;
		var wgUserGroups = null;
		var wgUserLanguage = "en";
		var wgContentLanguage = "en";
		var wgBreakFrames = false;
		var wgCurRevisionId = 281260022;
		var wgVersion = "1.15alpha";
		var wgEnableAPI = true;
		var wgEnableWriteAPI = true;
		var wgSeparatorTransformTable = ["", ""];
		var wgDigitTransformTable = ["", ""];
		var wgMWSuggestTemplate = "http://en.wikipedia.org/w/api.php?action=opensearch\x26search={searchTerms}\x26namespace={namespaces}\x26suggest";
		var wgDBname = "enwiki";
		var wgSearchNamespaces = [0];
		var wgMWSuggestMessages = ["with suggestions", "no suggestions"];
		var wgRestrictionEdit = [];
		var wgRestrictionMove = [];
		/*]]>*/</script>

		<script type="text/javascript" src="/skins-1.5/common/wikibits.js?207xx"><!-- wikibits js --></script>
		<!-- Head Scripts -->
		<script type="text/javascript" src="/skins-1.5/common/ajax.js?207xx"></script>
		<script type="text/javascript" src="/skins-1.5/common/mwsuggest.js?207xx"></script>
<script type="text/javascript">/*<![CDATA[*/
var wgNotice='';var wgNoticeLocal='';
/*]]>*/</script>		<script type="text/javascript" src="http://upload.wikimedia.org/centralnotice/wikipedia/en/centralnotice.js?207xx"></script>
		<script type="text/javascript" src="/w/index.php?title=-&amp;action=raw&amp;gen=js&amp;useskin=monobook"><!-- site js --></script>
	</head>
<body class="mediawiki ltr ns-0 ns-subject page-Etanercept skin-monobook">
	<div id="globalWrapper">
		<div id="column-content">
	<div id="content">
		<a name="top" id="top"></a>
		<div id="siteNotice"><script type='text/javascript'>if (wgNotice != '') document.writeln(wgNotice);</script></div>		<h1 id="firstHeading" class="firstHeading">Etanercept</h1>
		<div id="bodyContent">
			<h3 id="siteSub">From Wikipedia, the free encyclopedia</h3>
			<div id="contentSub"></div>
									<div id="jump-to-nav">Jump to: <a href="#column-one">navigation</a>, <a href="#searchInput">search</a></div>			<!-- start content -->
			<table id="drugInfoBox" style="float: right; clear: right; margin: 0 0 0.5em 1em; background: #ffffff;" class="toccolours" border="0" cellpadding="1" align="right" width="280">
<tr>
<td align="center" colspan="2"><a href="/wiki/File:Enbrel.jpg" class="image" title="Enbrel.jpg"><img alt="" src="http://upload.wikimedia.org/wikipedia/commons/3/3a/Enbrel.jpg" width="153" height="422" border="0" /></a></td>
</tr>
<tr>
<td align="center" colspan="2">
<div style="font-size:medium; line-height:167%;">Etanercept</div>
</td>
</tr>
<tr>
<td align="center" colspan="2" bgcolor="#DDDDDD"><b>Systematic (<a href="/wiki/International_Union_of_Pure_and_Applied_Chemistry_nomenclature" title="International Union of Pure and Applied Chemistry nomenclature" class="mw-redirect">IUPAC</a>) name</b></td>
</tr>
<tr>
<td bgcolor="#EEEEEE" style="text-align: center; vertical-align: top;" colspan="2"><span style="font-size:11px">Unable to be assigned</span></td>
</tr>
<tr>
<td colspan="2" bgcolor="#DDDDDD"><b>Identifiers</b></td>
</tr>
<tr>
<td bgcolor="#DDEEFF" width="90"><a href="/wiki/CAS_registry_number" title="CAS registry number">CAS number</a></td>
<td bgcolor="#EEEEEE"><span class="reflink plainlinksneverexpand"><a href="http://www.nlm.nih.gov/cgi/mesh/2009/MB_cgi?term=185243-69-0&amp;rn=1" class="external text" title="http://www.nlm.nih.gov/cgi/mesh/2009/MB_cgi?term=185243-69-0&amp;rn=1" rel="nofollow">185243-69-0</a></span></td>
</tr>
<tr>
<td bgcolor="#DDEEFF"><a href="/wiki/Anatomical_Therapeutic_Chemical_Classification_System" title="Anatomical Therapeutic Chemical Classification System">ATC code</a></td>
<td bgcolor="#EEEEEE"><a href="/wiki/ATC_code_L04" title="ATC code L04">L04</a><span class="reflink plainlinksneverexpand"><a href="http://www.whocc.no/atcddd/indexdatabase/index.php?query=L04AB01" class="external text" title="http://www.whocc.no/atcddd/indexdatabase/index.php?query=L04AB01" rel="nofollow">AB01</a></span></td>
</tr>
<tr>
<td bgcolor="#DDEEFF"><a href="/wiki/PubChem" title="PubChem">PubChem</a></td>
<td bgcolor="#EEEEEE"><span class="reflink plainlinksneverexpand"><a href="http://pubchem.ncbi.nlm.nih.gov/summary/summary.cgi?cid=N/A" class="external text" title="http://pubchem.ncbi.nlm.nih.gov/summary/summary.cgi?cid=N/A" rel="nofollow">N/A</a></span></td>
</tr>
<tr>
<td bgcolor="#DDEEFF"><a href="/wiki/DrugBank" title="DrugBank">DrugBank</a></td>
<td bgcolor="#EEEEEE"><span class="reflink plainlinksneverexpand"><a href="http://www.drugbank.ca/cgi-bin/show_drug.cgi?CARD=BTD00052" class="external text" title="http://www.drugbank.ca/cgi-bin/show_drug.cgi?CARD=BTD00052" rel="nofollow">BTD00052</a></span></td>
</tr>
<tr>
<td colspan="2" bgcolor="#DDDDDD"><b>Chemical data</b></td>
</tr>
<tr>
<td bgcolor="#DDEEFF"><a href="/wiki/Chemical_formula" title="Chemical formula">Formula</a></td>
<td bgcolor="#EEEEEE"><a href="/wiki/Carbon" title="Carbon"><span style="color: rgb(000,000,000); font-weight: bold;">C</span></a><sub>2224</sub><a href="/wiki/Hydrogen" title="Hydrogen"><span style="color: rgb(77,77,77); font-weight: bold;">H</span></a><sub>3475</sub><a href="/wiki/Nitrogen" title="Nitrogen"><span style="color: rgb(0,0,128); font-weight: bold;">N</span></a><sub>621</sub><a href="/wiki/Oxygen" title="Oxygen"><span style="color: rgb(116,35,35); font-weight: bold;">O</span></a><sub>698</sub><a href="/wiki/Sulfur" title="Sulfur"><span style="color: rgb(114,97,31); font-weight: bold;">S</span></a><sub>36</sub><sup>&#160;</sup></td>
</tr>
<tr>
<td bgcolor="#DDEEFF"><a href="/wiki/Molecular_mass" title="Molecular mass">Mol. mass</a></td>
<td bgcolor="#EEEEEE">51234.9 g/mol</td>
</tr>
<tr>
<td colspan="2" bgcolor="#DDDDDD"><b>Pharmacokinetic data</b></td>
</tr>
<tr>
<td bgcolor="#DDEEFF" style="vertical-align: top;"><a href="/wiki/Bioavailability" title="Bioavailability">Bioavailability</a></td>
<td bgcolor="#EEEEEE">58–76% (SC)</td>
</tr>
<tr>
<td bgcolor="#DDEEFF" style="vertical-align: top;"><a href="/wiki/Drug_metabolism" title="Drug metabolism">Metabolism</a></td>
<td bgcolor="#EEEEEE"><a href="/wiki/Reticuloendothelial" title="Reticuloendothelial" class="mw-redirect">Reticuloendothelial</a> system (speculative)</td>
</tr>
<tr>
<td bgcolor="#DDEEFF" style="vertical-align: top;"><a href="/wiki/Biological_half-life" title="Biological half-life">Half life</a></td>
<td bgcolor="#EEEEEE">70–132 hours</td>
</tr>
<tr>
<td bgcolor="#DDEEFF" style="vertical-align: top;"><a href="/wiki/Excretion" title="Excretion">Excretion</a></td>
<td bgcolor="#EEEEEE">&#160;?</td>
</tr>
<tr>
<td colspan="2" bgcolor="#DDDDDD"><b>Therapeutic considerations</b></td>
</tr>
<tr>
<td bgcolor="#DDEEFF" style="vertical-align: top;"><a href="/wiki/Pregnancy_category" title="Pregnancy category">Pregnancy cat.</a></td>
<td bgcolor="#EEEEEE">
<p>B2 <small>(<a href="/wiki/Australia" title="Australia">Au</a>)</small>, B <small>(<a href="/wiki/United_States" title="United States">U.S.</a>)</small></p>
</td>
</tr>
<tr>
<td bgcolor="#DDEEFF" style="vertical-align: top;"><a href="/wiki/Regulation_of_therapeutic_goods" title="Regulation of therapeutic goods">Legal status</a></td>
<td bgcolor="#EEEEEE">
<p>S4 <small>(Au)</small>, POM <small>(<a href="/wiki/United_Kingdom" title="United Kingdom">UK</a>)</small>, ℞-only <small>(U.S.)</small></p>
</td>
</tr>
<tr>
<td bgcolor="#DDEEFF" style="vertical-align: top;"><a href="/wiki/Route_of_administration" title="Route of administration">Routes</a></td>
<td bgcolor="#EEEEEE">Subcutaneous</td>
</tr>
</table>
<p><b>Etanercept</b> (Enbrel) is a drug that treats autoimmune diseases by interfering with the <a href="/wiki/CD120" title="CD120">TNF receptor</a>, a part of the immune system.</p>
<p>Etanercept is a <a href="/wiki/Recombinant" title="Recombinant">recombinant</a>-DNA drug made by combining two proteins (a fusion protein). It links human soluble <a href="/wiki/CD120" title="CD120">TNF receptor</a> to the <a href="/wiki/Fragment_crystallizable_region" title="Fragment crystallizable region">Fc</a> component of human <a href="/wiki/Immunoglobulin_G1" title="Immunoglobulin G1" class="mw-redirect">immunoglobulin G1</a> (IgG1) and acts as a <a href="/wiki/TNF_inhibitor" title="TNF inhibitor">TNF inhibitor</a>.</p>
<p>The prototypic fusion protein was first synthesized and shown to be highly active and unusually stable as a modality for blockade of TNF in vivo in the early 1990s by <a href="/wiki/Bruce_A._Beutler" title="Bruce A. Beutler">Bruce A. Beutler</a>, an academic researcher then at the <a href="/wiki/University_of_Texas_Southwestern_Medical_Center_at_Dallas" title="University of Texas Southwestern Medical Center at Dallas">University of Texas Southwestern Medical Center at Dallas</a>, and his colleagues,<sup id="cite_ref-0" class="reference"><a href="#cite_note-0" title=""><span>[</span>1<span>]</span></a></sup>.<sup id="cite_ref-1" class="reference"><a href="#cite_note-1" title=""><span>[</span>2<span>]</span></a></sup><sup id="cite_ref-2" class="reference"><a href="#cite_note-2" title=""><span>[</span>3<span>]</span></a></sup> These investigators also patented the protein,<sup id="cite_ref-3" class="reference"><a href="#cite_note-3" title=""><span>[</span>4<span>]</span></a></sup> selling all rights to its use to <a href="/wiki/Immunex" title="Immunex" class="mw-redirect">Immunex</a>, a biotechnology company that was acquired by <a href="/wiki/Amgen" title="Amgen">Amgen</a> in 2002.<sup id="cite_ref-title.7C.7C_DukeMedNews_.7C.7C_Arthritis_Drug_Effective_for_Depression_in_Psoriasis_Sufferers_4-0" class="reference"><a href="#cite_note-title.7C.7C_DukeMedNews_.7C.7C_Arthritis_Drug_Effective_for_Depression_in_Psoriasis_Sufferers-4" title=""><span>[</span>5<span>]</span></a></sup></p>
<p>It is a large molecule, with a molecular weight of 150 <a href="/wiki/KDa" title="KDa" class="mw-redirect">kDa</a>., that binds to TNFα and decreases its role in disorders involving excess inflammation in humans and other animals, including <a href="/wiki/Autoimmune_diseases" title="Autoimmune diseases" class="mw-redirect">autoimmune diseases</a> such as <a href="/wiki/Ankylosing_spondylitis" title="Ankylosing spondylitis">ankylosing spondylitis</a>,<sup id="cite_ref-pmid17389658_5-0" class="reference"><a href="#cite_note-pmid17389658-5" title=""><span>[</span>6<span>]</span></a></sup> <a href="/wiki/Juvenile_rheumatoid_arthritis" title="Juvenile rheumatoid arthritis" class="mw-redirect">juvenile rheumatoid arthritis</a>, <a href="/wiki/Psoriasis" title="Psoriasis">psoriasis</a>, <a href="/wiki/Psoriatic_arthritis" title="Psoriatic arthritis">psoriatic arthritis</a>, <a href="/wiki/Rheumatoid_arthritis" title="Rheumatoid arthritis">rheumatoid arthritis</a>, and, potentially, in a variety of other disorders mediated by excess TNFα.</p>
<p>This therapeutic potential is based on the fact that TNF-alpha is the "master regulator" (as coined by Marc Feldmann, Phd, and <a href="/wiki/Ravinder_N._Maini" title="Ravinder N. Maini">Ravinder N. Maini</a> BCh, recipients of the 2003 <a href="/wiki/Lasker_Award" title="Lasker Award">Lasker Award</a> for their anti-TNF research in rheumatoid arthritis) of the inflammatory response in many organ systems.<sup id="cite_ref-titleTNF_defined_as_a_therapeutic_target_for_rheumatoid_arthritis_and_other_autoimmune_diseases_-_Nature_Medicine_6-0" class="reference"><a href="#cite_note-titleTNF_defined_as_a_therapeutic_target_for_rheumatoid_arthritis_and_other_autoimmune_diseases_-_Nature_Medicine-6" title=""><span>[</span>7<span>]</span></a></sup></p>
<p>In North America, etanercept is co-marketed by <a href="/wiki/Amgen" title="Amgen">Amgen</a> and <a href="/wiki/Wyeth" title="Wyeth">Wyeth</a> under the trade name <b>Enbrel</b> in two separate formulations, one in powder form, the other as a pre-mixed liquid. Wyeth is the sole marketer of Enbrel outside of North America.</p>
<table id="toc" class="toc" summary="Contents">
<tr>
<td>
<div id="toctitle">
<h2>Contents</h2>
</div>
<ul>
<li class="toclevel-1"><a href="#Development"><span class="tocnumber">1</span> <span class="toctext">Development</span></a></li>
<li class="toclevel-1"><a href="#Mode_of_action"><span class="tocnumber">2</span> <span class="toctext">Mode of action</span></a></li>
<li class="toclevel-1"><a href="#Structure"><span class="tocnumber">3</span> <span class="toctext">Structure</span></a></li>
<li class="toclevel-1"><a href="#Licensed_indications"><span class="tocnumber">4</span> <span class="toctext">Licensed indications</span></a></li>
<li class="toclevel-1"><a href="#Administration"><span class="tocnumber">5</span> <span class="toctext">Administration</span></a></li>
<li class="toclevel-1"><a href="#Safety"><span class="tocnumber">6</span> <span class="toctext">Safety</span></a></li>
<li class="toclevel-1"><a href="#Sales"><span class="tocnumber">7</span> <span class="toctext">Sales</span></a></li>
<li class="toclevel-1"><a href="#Experimental.2Foff-label_uses"><span class="tocnumber">8</span> <span class="toctext">Experimental/off-label uses</span></a></li>
<li class="toclevel-1"><a href="#Similar_agents"><span class="tocnumber">9</span> <span class="toctext">Similar agents</span></a></li>
<li class="toclevel-1"><a href="#References"><span class="tocnumber">10</span> <span class="toctext">References</span></a></li>
<li class="toclevel-1"><a href="#External_links"><span class="tocnumber">11</span> <span class="toctext">External links</span></a></li>
</ul>
</td>
</tr>
</table>
<script type="text/javascript">
//<![CDATA[
 if (window.showTocToggle) { var tocShowText = "show"; var tocHideText = "hide"; showTocToggle(); } 
//]]>
</script>
<p><a name="Development" id="Development"></a></p>
<h2><span class="editsection">[<a href="/w/index.php?title=Etanercept&amp;action=edit&amp;section=1" title="Edit section: Development">edit</a>]</span> <span class="mw-headline">Development</span></h2>
<p>Etanercept was developed by researchers at Immunex, and was released for commercial use in late 1998, soon after the release of <a href="/wiki/Infliximab" title="Infliximab">infliximab</a> (<i>Remicade</i>) – the first chimeric <a href="/wiki/Monoclonal_antibody" title="Monoclonal antibody" class="mw-redirect">monoclonal antibody</a> against TNFα to be marketed for clinical use.</p>
<p>Etanercept is a <a href="/wiki/Dimer" title="Dimer">dimeric molecule</a>,<sup id="cite_ref-pmid11712048_7-0" class="reference"><a href="#cite_note-pmid11712048-7" title=""><span>[</span>8<span>]</span></a></sup> and this dimeric structure is necessary for its proper therapeutic activity. During its development at Immunex Corporation an earlier monomeric version did not have sufficient biologic activity.</p>
<p><a name="Mode_of_action" id="Mode_of_action"></a></p>
<h2><span class="editsection">[<a href="/w/index.php?title=Etanercept&amp;action=edit&amp;section=2" title="Edit section: Mode of action">edit</a>]</span> <span class="mw-headline">Mode of action</span></h2>
<p>It reduces the effect of naturally present TNF, and hence is a <a href="/wiki/TNF_inhibitor" title="TNF inhibitor">TNF inhibitor</a>.</p>
<p>Tumor necrosis factor-alpha (TNFα) is a <a href="/wiki/Cytokine" title="Cytokine">cytokine</a> produced by <a href="/wiki/Monocyte" title="Monocyte">monocytes</a> and <a href="/wiki/Macrophage" title="Macrophage">macrophages</a>, two types of <a href="/wiki/White_blood_cell" title="White blood cell">white blood cells</a>. It mediates the immune response by increasing the transport of white blood cells to sites of <a href="/wiki/Inflammation" title="Inflammation">inflammation</a>, and through additional molecular mechanisms which initiate and amplify inflammation. Inhibition of its action by etanercept reduces the inflammatory response which is especially useful for treating <a href="/wiki/Autoimmune_disease" title="Autoimmune disease">autoimmune diseases</a>.</p>
<p>There are two types of TNF <a href="/wiki/Receptor_(biochemistry)" title="Receptor (biochemistry)">receptors</a>: those found embedded in white blood cells that respond to TNF by releasing other cytokines, and <i>soluble</i> TNF receptors which are used to deactivate TNF and blunt the immune response. In addition, TNF receptors are found on the surface of virtually all nucleated cells (red blood cells, which are not nucleated, do not contain TNF receptors on their surface). Etanercept mimics the inhibitory effects of naturally occurring soluble TNF receptors, the difference being that etanercept, because it is a fusion protein rather than a simple TNF receptor, has a greatly extended half-life in the bloodstream, and therefore a more profound and long-lasting biologic effect than a naturally occurring soluble TNF receptor.<sup id="cite_ref-pmid16135466_8-0" class="reference"><a href="#cite_note-pmid16135466-8" title=""><span>[</span>9<span>]</span></a></sup></p>
<p><a name="Structure" id="Structure"></a></p>
<h2><span class="editsection">[<a href="/w/index.php?title=Etanercept&amp;action=edit&amp;section=3" title="Edit section: Structure">edit</a>]</span> <span class="mw-headline">Structure</span></h2>
<p>Etanercept is made from the combination of two naturally occurring soluble human 75-kilodalton TNF receptors linked to an Fc portion of an IgG1. The effect is an artificially engineered dimeric fusion protein.</p>
<p><a name="Licensed_indications" id="Licensed_indications"></a></p>
<h2><span class="editsection">[<a href="/w/index.php?title=Etanercept&amp;action=edit&amp;section=4" title="Edit section: Licensed indications">edit</a>]</span> <span class="mw-headline">Licensed indications</span></h2>
<p>In the USA the FDA has licenced Enbrel for&#160;:</p>
<ul>
<li>Moderate to Severe Rheumatoid Arthritis (RA) (Nov 1998)</li>
<li>Moderate to Severe Polyarticular Juvenile Idiopathic Arthritis (JIA) (1999)</li>
<li>Psoriatic Arthritis (2002)</li>
<li>Ankylosing Spondylitis (AS) (July 2003)<sup id="cite_ref-9" class="reference"><a href="#cite_note-9" title=""><span>[</span>10<span>]</span></a></sup></li>
<li>Moderate to Severe Plaque Psoriasis (April 2004)</li>
</ul>
<p><a name="Administration" id="Administration"></a></p>
<h2><span class="editsection">[<a href="/w/index.php?title=Etanercept&amp;action=edit&amp;section=5" title="Edit section: Administration">edit</a>]</span> <span class="mw-headline">Administration</span></h2>
<p>Enbrel is marketed as a <a href="/wiki/Freeze_drying" title="Freeze drying">lyophylized</a> powder in 25&#160;mg vials which must be reconstituted with a <a href="/wiki/Diluent" title="Diluent">diluent</a> and then <a href="/wiki/Injection_(medicine)" title="Injection (medicine)">injected subcutaneously</a>, typically by the patient at home.</p>
<p>Because patients with arthritis found the reconstitution procedure difficult, it was made available as pre-filled 50&#160;mg/ml syringes in late 2004 and a single-use 50&#160;mg autoinjector "pen" was brought to market in mid-2006.<sup id="cite_ref-titleEnbrel_and_Humira_Now_Have_Automated_Delivery_System_10-0" class="reference"><a href="#cite_note-titleEnbrel_and_Humira_Now_Have_Automated_Delivery_System-10" title=""><span>[</span>11<span>]</span></a></sup></p>
<p>It cannot be administered <a href="/wiki/Route_of_administration" title="Route of administration">orally</a>, because the <a href="/wiki/Digestive_system" title="Digestive system" class="mw-redirect">digestive system</a> would destroy the drug.</p>
<p>FDA approved dose is 25&#160;mg BIW (twice weekly) or 50&#160;mg QW (once weekly).</p>
<p><a name="Safety" id="Safety"></a></p>
<h2><span class="editsection">[<a href="/w/index.php?title=Etanercept&amp;action=edit&amp;section=6" title="Edit section: Safety">edit</a>]</span> <span class="mw-headline">Safety</span></h2>
<p>All <a href="/wiki/TNF_inhibitor" title="TNF inhibitor">TNF inhibitors</a> are <a href="/wiki/Immunosuppressant" title="Immunosuppressant">immunosuppressants</a>. After a number of studies and reports of adverse reactions in patients receiving anti-TNF alpha therapy (including serious and sometimes fatal blood disorders, <a href="/wiki/Infection" title="Infection">infections</a>, rare reports of <a href="/wiki/Lymphoma" title="Lymphoma">lymphoma</a> and solid tissue cancers, rare reports of serious liver injury, and rare reports of <a href="/wiki/Demyelinating" title="Demyelinating" class="mw-redirect">demyelinating</a> <a href="/wiki/Central_nervous_system" title="Central nervous system">central nervous system</a> disorders), rare reports of <a href="/wiki/Congestive_heart_failure" title="Congestive heart failure" class="mw-redirect">congestive heart failure</a>, the U.S. <a href="/wiki/Food_and_Drug_Administration" title="Food and Drug Administration" class="mw-redirect">Food and Drug Administration</a> issued a warning to doctors appearing in the respective product labeling of these drugs instructing them to screen and monitor potential patients more carefully.<sup id="cite_ref-titlePrescribing_Information_-_ENBREL_11-0" class="reference"><a href="#cite_note-titlePrescribing_Information_-_ENBREL-11" title=""><span>[</span>12<span>]</span></a></sup></p>
<p>Although these three agents - etanercept, infliximab and adalimumab - are all biologic <a href="/wiki/Anti-TNF" title="Anti-TNF" class="mw-redirect">anti-TNF</a> therapeutics, their methods of administration, dosing, and side effect profiles are somewhat different. These differences may be accounted for by fundamental differences in their biologic structure. Both infliximab and adalimumab fix <a href="/wiki/Complement_system" title="Complement system">complement</a>, and have the ability to <a href="/wiki/Lyze" title="Lyze" class="mw-redirect">lyze</a> cells. While potentially contributing to their therapeutic efficacy in disorders such as <a href="/wiki/Crohn%27s_disease" title="Crohn's disease">Crohn's disease</a> (for which both of these monoclonal antibodies are now <a href="/wiki/Food_and_Drug_Administration" title="Food and Drug Administration" class="mw-redirect">FDA</a>-approved), these mABs also carry <a href="/wiki/Black-box_warning" title="Black-box warning" class="mw-redirect">black-box warnings</a>. In addition infliximab has a higher propensity for the development of <a href="/wiki/Anaphylaxis" title="Anaphylaxis">anaphylaxis</a>, perhaps as a result both of its <a href="/wiki/Chimeric" title="Chimeric" class="mw-redirect">chimeric</a> structure and its <a href="/wiki/Intravenous" title="Intravenous" class="mw-redirect">intravenous</a> route of administration.</p>
<p>On May 2, 2008, the FDA placed a black box warning on etanercept due to a number of serious infections associated with the drug.<sup id="cite_ref-Wyeth_and_Amgen_12-0" class="reference"><a href="#cite_note-Wyeth_and_Amgen-12" title=""><span>[</span>13<span>]</span></a></sup></p>
<p><a name="Sales" id="Sales"></a></p>
<h2><span class="editsection">[<a href="/w/index.php?title=Etanercept&amp;action=edit&amp;section=7" title="Edit section: Sales">edit</a>]</span> <span class="mw-headline">Sales</span></h2>
<p>Enbrel is the most widely used anti-TNF biologic drug in the field of <a href="/wiki/Rheumatology" title="Rheumatology">rheumatology</a> with more patients taking this drug for that<sup class="noprint Inline-Template"><span title="The text in the vicinity of this tag needs clarification or removal of jargon&#160;from February 2009" style="white-space: nowrap;">[<i><a href="/wiki/Wikipedia:Please_clarify" title="Wikipedia:Please clarify">clarification needed</a></i>]</span></sup> indication than either Remicade (<a href="/wiki/Infliximab" title="Infliximab">infliximab</a>) or Humira (<a href="/wiki/Adalimumab" title="Adalimumab">adalimumab</a>)<sup class="noprint Template-Fact"><span title="This claim needs references to reliable sources&#160;since June 2007" style="white-space: nowrap;">[<i><a href="/wiki/Wikipedia:Citation_needed" title="Wikipedia:Citation needed">citation needed</a></i>]</span></sup>. However Infliximab is the most widely used anti-TNF biologic drug when all FDA approved indications (uses) of the drugs are considered,<sup class="noprint Template-Fact"><span title="This claim needs references to reliable sources&#160;since January 2009" style="white-space: nowrap;">[<i><a href="/wiki/Wikipedia:Citation_needed" title="Wikipedia:Citation needed">citation needed</a></i>]</span></sup> including <a href="/wiki/Crohn%27s_disease" title="Crohn's disease">Crohn's disease</a> and <a href="/wiki/Ulcerative_colitis" title="Ulcerative colitis">ulcerative colitis</a>, two autoimmune diseases for which etanercept does not have an FDA approved indication. In addition to their<sup class="noprint Inline-Template"><span title="The text in the vicinity of this tag needs clarification or removal of jargon&#160;from February 2009" style="white-space: nowrap;">[<i><a href="/wiki/Wikipedia:Please_clarify" title="Wikipedia:Please clarify">clarification needed</a></i>]</span></sup> labeled indications, there are multiple published, peer-reviewed scientific studies suggesting potential uses for off-label indications, for which the FDA has not verified either safety or efficacy.</p>
<p><a name="Experimental.2Foff-label_uses" id="Experimental.2Foff-label_uses"></a></p>
<h2><span class="editsection">[<a href="/w/index.php?title=Etanercept&amp;action=edit&amp;section=8" title="Edit section: Experimental/off-label uses">edit</a>]</span> <span class="mw-headline">Experimental/off-label uses</span></h2>
<p>Given the central role of TNF-alpha in many diseases, etanercept is being studied as treatment for a number of these disease, including over 150 clinical trials.<sup id="cite_ref-13" class="reference"><a href="#cite_note-13" title=""><span>[</span>14<span>]</span></a></sup> This includes certain forms of <a href="/wiki/Vasculitis" title="Vasculitis">vasculitis</a> (such as <a href="/wiki/Wegener%27s_granulomatosis" title="Wegener's granulomatosis">Wegener's granulomatosis</a>, in which it was not effective).<sup id="cite_ref-14" class="reference"><a href="#cite_note-14" title=""><span>[</span>15<span>]</span></a></sup></p>
<p><b>Alzheimer's disease</b>: A 2006 pilot study showed small but significant improvements in various cognitive rating scales in patients with <a href="/wiki/Alzheimer%27s_disease" title="Alzheimer's disease">Alzheimer's disease</a> (AD) after treatment with etanercept.<sup id="cite_ref-pmid16926764_15-0" class="reference"><a href="#cite_note-pmid16926764-15" title=""><span>[</span>16<span>]</span></a></sup> A further study, administering to a single AD patient via perispinal infusion, showed rapid and significant improvement in Alzheimer's symptoms.<sup id="cite_ref-tobinick2008_16-0" class="reference"><a href="#cite_note-tobinick2008-16" title=""><span>[</span>17<span>]</span></a></sup> A small number of US physicians offer etanercept treatment for AD at a cost of $10,000 to $40,000 per annum.<sup id="cite_ref-17" class="reference"><a href="#cite_note-17" title=""><span>[</span>18<span>]</span></a></sup></p>
<p><a name="Similar_agents" id="Similar_agents"></a></p>
<h2><span class="editsection">[<a href="/w/index.php?title=Etanercept&amp;action=edit&amp;section=9" title="Edit section: Similar agents">edit</a>]</span> <span class="mw-headline">Similar agents</span></h2>
<ul>
<li><a href="/wiki/Infliximab" title="Infliximab">Infliximab</a></li>
<li><a href="/wiki/Adalimumab" title="Adalimumab">Adalimumab</a></li>
<li><a href="/wiki/Certolizumab_pegol" title="Certolizumab pegol">Certolizumab pegol</a></li>
</ul>
<p><a name="References" id="References"></a></p>
<h2><span class="editsection">[<a href="/w/index.php?title=Etanercept&amp;action=edit&amp;section=10" title="Edit section: References">edit</a>]</span> <span class="mw-headline">References</span></h2>
<table class="metadata plainlinks mbox-small" style="border:1px solid #aaa; background-color:#f9f9f9;">
<tr>
<td class="mbox-image"><a href="http://commons.wikimedia.org/wiki/Special:Search/Etanercept" title="commons:Special:Search/Etanercept"><img alt="Sister project" src="http://upload.wikimedia.org/wikipedia/en/thumb/4/4a/Commons-logo.svg/40px-Commons-logo.svg.png" width="40" height="54" border="0" /></a></td>
<td class="mbox-text" style=""><a href="/wiki/Wikimedia_Commons" title="Wikimedia Commons">Wikimedia Commons</a> has media related to: <b><i><a href="http://commons.wikimedia.org/wiki/Category:Etanercept" class="extiw" title="commons:Category:Etanercept">Etanercept</a> </i></b></td>
</tr>
</table>
<div class="references-small references-column-count references-column-count-2" style="-moz-column-count:2; column-count:2;">
<ol class="references">
<li id="cite_note-0"><b><a href="#cite_ref-0" title="">^</a></b> Peppel,K. et al. A tumor necrosis factor (TNF) receptor-IgG heavy chain chimeric protein as a bivalent antagonist of TNF activity. J.Exp.Med. 174(6):1483-9, 1991</li>
<li id="cite_note-1"><b><a href="#cite_ref-1" title="">^</a></b> Peppel,K. et al. Expression of a TNF inhibitor in transgenic mice. J.Immunol. 151(10):5699-703, 1993</li>
<li id="cite_note-2"><b><a href="#cite_ref-2" title="">^</a></b> Kolls,J. et al. Prolonged and effective blockade of tumor necrosis factor activity through adenovirus-mediated gene transfer. Proc.Natl.Acad.Sci.USA 91(1):215-9, 1994</li>
<li id="cite_note-3"><b><a href="#cite_ref-3" title="">^</a></b> U.S. Patent number: 5,447,851</li>
<li id="cite_note-title.7C.7C_DukeMedNews_.7C.7C_Arthritis_Drug_Effective_for_Depression_in_Psoriasis_Sufferers-4"><b><a href="#cite_ref-title.7C.7C_DukeMedNews_.7C.7C_Arthritis_Drug_Effective_for_Depression_in_Psoriasis_Sufferers_4-0" title="">^</a></b> <cite style="font-style:normal" class="web"><a href="http://www.dukemednews.org/news/article.php?id=9419" class="external text" title="http://www.dukemednews.org/news/article.php?id=9419" rel="nofollow">"Arthritis Drug Effective for Depression in Psoriasis Sufferers"</a><span class="printonly">. <a href="http://www.dukemednews.org/news/article.php?id=9419" class="external free" title="http://www.dukemednews.org/news/article.php?id=9419" rel="nofollow">http://www.dukemednews.org/news/article.php?id=9419</a></span><span class="reference-accessdate">. Retrieved on 2008-01-10</span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=bookitem&amp;rft.btitle=Arthritis+Drug+Effective+for+Depression+in+Psoriasis+Sufferers&amp;rft.atitle=&amp;rft_id=http%3A%2F%2Fwww.dukemednews.org%2Fnews%2Farticle.php%3Fid%3D9419&amp;rfr_id=info:sid/en.wikipedia.org:Etanercept"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-pmid17389658-5"><b><a href="#cite_ref-pmid17389658_5-0" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFBraun_J.2C_McHugh_N.2C_Singh_A.2C_Wajdula_JS.2C_Sato_R2007">Braun J, McHugh N, Singh A, Wajdula JS, Sato R (2007). "<a href="http://rheumatology.oxfordjournals.org/cgi/content/full/46/6/999" class="external text" title="http://rheumatology.oxfordjournals.org/cgi/content/full/46/6/999" rel="nofollow">Improvement in patient-reported outcomes for patients with ankylosing spondylitis treated with etanercept 50 mg once-weekly and 25 mg twice-weekly</a>". <i><a href="/wiki/Rheumatology_(Oxford)" title="Rheumatology (Oxford)" class="mw-redirect">Rheumatology (Oxford)</a></i> <b>46</b> (6): 999–1004. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1093%2Frheumatology%2Fkem069" class="external text" title="http://dx.doi.org/10.1093%2Frheumatology%2Fkem069" rel="nofollow">10.1093/rheumatology/kem069</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/17389658" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/17389658">PMID 17389658</a><span class="printonly">. <a href="http://rheumatology.oxfordjournals.org/cgi/content/full/46/6/999" class="external free" title="http://rheumatology.oxfordjournals.org/cgi/content/full/46/6/999" rel="nofollow">http://rheumatology.oxfordjournals.org/cgi/content/full/46/6/999</a></span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Improvement+in+patient-reported+outcomes+for+patients+with+ankylosing+spondylitis+treated+with+etanercept+50+mg+once-weekly+and+25+mg+twice-weekly&amp;rft.jtitle=%5B%5BRheumatology+%28Oxford%29%5D%5D&amp;rft.aulast=Braun+J%2C+McHugh+N%2C+Singh+A%2C+Wajdula+JS%2C+Sato+R&amp;rft.au=Braun+J%2C+McHugh+N%2C+Singh+A%2C+Wajdula+JS%2C+Sato+R&amp;rft.date=2007&amp;rft.volume=46&amp;rft.issue=6&amp;rft.pages=999%E2%80%931004&amp;rft_id=info:doi/10.1093%2Frheumatology%2Fkem069&amp;rft_id=info:pmid/17389658&amp;rft_id=http%3A%2F%2Frheumatology.oxfordjournals.org%2Fcgi%2Fcontent%2Ffull%2F46%2F6%2F999&amp;rfr_id=info:sid/en.wikipedia.org:Etanercept"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-titleTNF_defined_as_a_therapeutic_target_for_rheumatoid_arthritis_and_other_autoimmune_diseases_-_Nature_Medicine-6"><b><a href="#cite_ref-titleTNF_defined_as_a_therapeutic_target_for_rheumatoid_arthritis_and_other_autoimmune_diseases_-_Nature_Medicine_6-0" title="">^</a></b> <cite style="font-style:normal" class="web"><a href="http://www.nature.com/nm/journal/v9/n10/full/nm939.html" class="external text" title="http://www.nature.com/nm/journal/v9/n10/full/nm939.html" rel="nofollow">"TNF defined as a therapeutic target for rheumatoid arthritis and other autoimmune diseases - Nature Medicine"</a><span class="printonly">. <a href="http://www.nature.com/nm/journal/v9/n10/full/nm939.html" class="external free" title="http://www.nature.com/nm/journal/v9/n10/full/nm939.html" rel="nofollow">http://www.nature.com/nm/journal/v9/n10/full/nm939.html</a></span><span class="reference-accessdate">. Retrieved on 2008-01-10</span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=bookitem&amp;rft.btitle=TNF+defined+as+a+therapeutic+target+for+rheumatoid+arthritis+and+other+autoimmune+diseases+-+Nature+Medicine&amp;rft.atitle=&amp;rft_id=http%3A%2F%2Fwww.nature.com%2Fnm%2Fjournal%2Fv9%2Fn10%2Ffull%2Fnm939.html&amp;rfr_id=info:sid/en.wikipedia.org:Etanercept"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-pmid11712048-7"><b><a href="#cite_ref-pmid11712048_7-0" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFSmith_KJ.2C_Skelton_HG2001">Smith KJ, Skelton HG (2001). "<a href="http://linkinghub.elsevier.com/retrieve/pii/S0190-9622(01)47789-9" class="external text" title="http://linkinghub.elsevier.com/retrieve/pii/S0190-9622(01)47789-9" rel="nofollow">Rapid onset of cutaneous squamous cell carcinoma in patients with rheumatoid arthritis after starting tumor necrosis factor alpha receptor IgG1-Fc fusion complex therapy</a>". <i><a href="/wiki/J._Am._Acad._Dermatol." title="J. Am. Acad. Dermatol." class="mw-redirect">J. Am. Acad. Dermatol.</a></i> <b>45</b> (6): 953–6. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1067%2Fmjd.2001.117725" class="external text" title="http://dx.doi.org/10.1067%2Fmjd.2001.117725" rel="nofollow">10.1067/mjd.2001.117725</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/11712048" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/11712048">PMID 11712048</a><span class="printonly">. <a href="http://linkinghub.elsevier.com/retrieve/pii/S0190-9622(01)47789-9" class="external free" title="http://linkinghub.elsevier.com/retrieve/pii/S0190-9622(01)47789-9" rel="nofollow">http://linkinghub.elsevier.com/retrieve/pii/S0190-9622(01)47789-9</a></span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Rapid+onset+of+cutaneous+squamous+cell+carcinoma+in+patients+with+rheumatoid+arthritis+after+starting+tumor+necrosis+factor+alpha+receptor+IgG1-Fc+fusion+complex+therapy&amp;rft.jtitle=%5B%5BJ.+Am.+Acad.+Dermatol.%5D%5D&amp;rft.aulast=Smith+KJ%2C+Skelton+HG&amp;rft.au=Smith+KJ%2C+Skelton+HG&amp;rft.date=2001&amp;rft.volume=45&amp;rft.issue=6&amp;rft.pages=953%E2%80%936&amp;rft_id=info:doi/10.1067%2Fmjd.2001.117725&amp;rft_id=info:pmid/11712048&amp;rft_id=http%3A%2F%2Flinkinghub.elsevier.com%2Fretrieve%2Fpii%2FS0190-9622%2801%2947789-9&amp;rfr_id=info:sid/en.wikipedia.org:Etanercept"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-pmid16135466-8"><b><a href="#cite_ref-pmid16135466_8-0" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFMadhusudan_S.2C_Muthuramalingam_SR.2C_Braybrooke_JP.2C_.27.27et_al.27.272005">Madhusudan S, Muthuramalingam SR, Braybrooke JP, <i>et al</i> (2005). "<a href="http://jco.ascopubs.org/cgi/content/full/23/25/5950" class="external text" title="http://jco.ascopubs.org/cgi/content/full/23/25/5950" rel="nofollow">Study of etanercept, a tumor necrosis factor-alpha inhibitor, in recurrent ovarian cancer</a>". <i>J. Clin. Oncol.</i> <b>23</b> (25): 5950–9. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1200%2FJCO.2005.04.127" class="external text" title="http://dx.doi.org/10.1200%2FJCO.2005.04.127" rel="nofollow">10.1200/JCO.2005.04.127</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/16135466" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/16135466">PMID 16135466</a><span class="printonly">. <a href="http://jco.ascopubs.org/cgi/content/full/23/25/5950" class="external free" title="http://jco.ascopubs.org/cgi/content/full/23/25/5950" rel="nofollow">http://jco.ascopubs.org/cgi/content/full/23/25/5950</a></span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Study+of+etanercept%2C+a+tumor+necrosis+factor-alpha+inhibitor%2C+in+recurrent+ovarian+cancer&amp;rft.jtitle=J.+Clin.+Oncol.&amp;rft.aulast=Madhusudan+S%2C+Muthuramalingam+SR%2C+Braybrooke+JP%2C+%27%27et+al%27%27&amp;rft.au=Madhusudan+S%2C+Muthuramalingam+SR%2C+Braybrooke+JP%2C+%27%27et+al%27%27&amp;rft.date=2005&amp;rft.volume=23&amp;rft.issue=25&amp;rft.pages=5950%E2%80%939&amp;rft_id=info:doi/10.1200%2FJCO.2005.04.127&amp;rft_id=info:pmid/16135466&amp;rft_id=http%3A%2F%2Fjco.ascopubs.org%2Fcgi%2Fcontent%2Ffull%2F23%2F25%2F5950&amp;rfr_id=info:sid/en.wikipedia.org:Etanercept"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-9"><b><a href="#cite_ref-9" title="">^</a></b> <a href="http://www.fda.gov/bbs/topics/ANSWERS/2003/ANS01240.html" class="external free" title="http://www.fda.gov/bbs/topics/ANSWERS/2003/ANS01240.html" rel="nofollow">http://www.fda.gov/bbs/topics/ANSWERS/2003/ANS01240.html</a> FDA</li>
<li id="cite_note-titleEnbrel_and_Humira_Now_Have_Automated_Delivery_System-10"><b><a href="#cite_ref-titleEnbrel_and_Humira_Now_Have_Automated_Delivery_System_10-0" title="">^</a></b> <cite style="font-style:normal" class="web"><a href="http://www.hopkins-arthritis.org/arthritis-news/2006/automated_delivery.html" class="external text" title="http://www.hopkins-arthritis.org/arthritis-news/2006/automated_delivery.html" rel="nofollow">"Enbrel and Humira Now Have Automated Delivery System"</a><span class="printonly">. <a href="http://www.hopkins-arthritis.org/arthritis-news/2006/automated_delivery.html" class="external free" title="http://www.hopkins-arthritis.org/arthritis-news/2006/automated_delivery.html" rel="nofollow">http://www.hopkins-arthritis.org/arthritis-news/2006/automated_delivery.html</a></span><span class="reference-accessdate">. Retrieved on 2008-01-10</span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=bookitem&amp;rft.btitle=Enbrel+and+Humira+Now+Have+Automated+Delivery+System&amp;rft.atitle=&amp;rft_id=http%3A%2F%2Fwww.hopkins-arthritis.org%2Farthritis-news%2F2006%2Fautomated_delivery.html&amp;rfr_id=info:sid/en.wikipedia.org:Etanercept"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-titlePrescribing_Information_-_ENBREL-11"><b><a href="#cite_ref-titlePrescribing_Information_-_ENBREL_11-0" title="">^</a></b> <cite style="font-style:normal" class="web"><a href="http://www.enbrel.com/prescribing-information.jsp" class="external text" title="http://www.enbrel.com/prescribing-information.jsp" rel="nofollow">"Prescribing Information - ENBREL"</a><span class="printonly">. <a href="http://www.enbrel.com/prescribing-information.jsp" class="external free" title="http://www.enbrel.com/prescribing-information.jsp" rel="nofollow">http://www.enbrel.com/prescribing-information.jsp</a></span><span class="reference-accessdate">. Retrieved on 2008-01-10</span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=bookitem&amp;rft.btitle=Prescribing+Information+-+ENBREL&amp;rft.atitle=&amp;rft_id=http%3A%2F%2Fwww.enbrel.com%2Fprescribing-information.jsp&amp;rfr_id=info:sid/en.wikipedia.org:Etanercept"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-Wyeth_and_Amgen-12"><b><a href="#cite_ref-Wyeth_and_Amgen_12-0" title="">^</a></b> <cite style="font-style:normal" class="web"><a href="http://money.cnn.com/news/newsfeeds/articles/apwire/21965cf0a650a8b5897142bfcbccb427.htm" class="external text" title="http://money.cnn.com/news/newsfeeds/articles/apwire/21965cf0a650a8b5897142bfcbccb427.htm" rel="nofollow">"Wyeth and Amgen heighten warning of life-threatening infections on skin drug Enbrel"</a><span class="printonly">. <a href="http://money.cnn.com/news/newsfeeds/articles/apwire/21965cf0a650a8b5897142bfcbccb427.htm" class="external free" title="http://money.cnn.com/news/newsfeeds/articles/apwire/21965cf0a650a8b5897142bfcbccb427.htm" rel="nofollow">http://money.cnn.com/news/newsfeeds/articles/apwire/21965cf0a650a8b5897142bfcbccb427.htm</a></span><span class="reference-accessdate">. Retrieved on 2008-05-02</span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=bookitem&amp;rft.btitle=Wyeth+and+Amgen+heighten+warning+of+life-threatening+infections+on+skin+drug+Enbrel&amp;rft.atitle=&amp;rft_id=http%3A%2F%2Fmoney.cnn.com%2Fnews%2Fnewsfeeds%2Farticles%2Fapwire%2F21965cf0a650a8b5897142bfcbccb427.htm&amp;rfr_id=info:sid/en.wikipedia.org:Etanercept"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-13"><b><a href="#cite_ref-13" title="">^</a></b> <a href="http://clinicaltrials.gov" class="external text" title="http://clinicaltrials.gov" rel="nofollow">FDA Clinical Trials database</a></li>
<li id="cite_note-14"><b><a href="#cite_ref-14" title="">^</a></b> <cite style="font-style:normal" class="">"<a href="http://content.nejm.org/cgi/content/full/352/4/351" class="external text" title="http://content.nejm.org/cgi/content/full/352/4/351" rel="nofollow">Etanercept plus standard therapy for Wegener's granulomatosis</a>". <i>N. Engl. J. Med.</i> <b>352</b> (4): 351–61. 2005. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1056%2FNEJMoa041884" class="external text" title="http://dx.doi.org/10.1056%2FNEJMoa041884" rel="nofollow">10.1056/NEJMoa041884</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/15673801" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/15673801">PMID 15673801</a><span class="printonly">. <a href="http://content.nejm.org/cgi/content/full/352/4/351" class="external free" title="http://content.nejm.org/cgi/content/full/352/4/351" rel="nofollow">http://content.nejm.org/cgi/content/full/352/4/351</a></span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Etanercept+plus+standard+therapy+for+Wegener%27s+granulomatosis&amp;rft.jtitle=N.+Engl.+J.+Med.&amp;rft.date=2005&amp;rft.volume=352&amp;rft.issue=4&amp;rft.pages=351%E2%80%9361&amp;rft_id=info:doi/10.1056%2FNEJMoa041884&amp;rft_id=info:pmid/15673801&amp;rft_id=http%3A%2F%2Fcontent.nejm.org%2Fcgi%2Fcontent%2Ffull%2F352%2F4%2F351&amp;rfr_id=info:sid/en.wikipedia.org:Etanercept"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-pmid16926764-15"><b><a href="#cite_ref-pmid16926764_15-0" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFTobinick_Edward_L..2C_Gross_H.2C_Weinberger_A.2C_Cohen_H2006">Tobinick Edward L., Gross H, Weinberger A, Cohen H (2006). "<a href="http://www.medscape.com/viewarticle/529176" class="external text" title="http://www.medscape.com/viewarticle/529176" rel="nofollow">TNF-alpha modulation for treatment of Alzheimer's disease: a 6-month pilot study</a>". <i><a href="/wiki/MedGenMed" title="MedGenMed" class="mw-redirect">MedGenMed</a></i> <b>8</b> (2): 25. <a href="http://www.ncbi.nlm.nih.gov/pubmed/16926764" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/16926764">PMID 16926764</a><span class="printonly">. <a href="http://www.medscape.com/viewarticle/529176" class="external free" title="http://www.medscape.com/viewarticle/529176" rel="nofollow">http://www.medscape.com/viewarticle/529176</a></span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=TNF-alpha+modulation+for+treatment+of+Alzheimer%27s+disease%3A+a+6-month+pilot+study&amp;rft.jtitle=%5B%5BMedGenMed%5D%5D&amp;rft.aulast=Tobinick+Edward+L.%2C+Gross+H%2C+Weinberger+A%2C+Cohen+H&amp;rft.au=Tobinick+Edward+L.%2C+Gross+H%2C+Weinberger+A%2C+Cohen+H&amp;rft.date=2006&amp;rft.volume=8&amp;rft.issue=2&amp;rft.pages=25&amp;rft_id=info:pmid/16926764&amp;rft_id=http%3A%2F%2Fwww.medscape.com%2Fviewarticle%2F529176&amp;rfr_id=info:sid/en.wikipedia.org:Etanercept"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-tobinick2008-16"><b><a href="#cite_ref-tobinick2008_16-0" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFTobinick_Edward_L..2C_Gross_H.2008">Tobinick Edward L., Gross H. (2008). "<a href="http://www.jneuroinflammation.com/content/5/1/2" class="external text" title="http://www.jneuroinflammation.com/content/5/1/2" rel="nofollow">Rapid cognitive improvement in Alzheimer's disease following perispinal etanercept administration</a>". <i>J. Neuroinflammation</i> <b>5</b> (2): 2. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1186%2F1742-2094-5-2" class="external text" title="http://dx.doi.org/10.1186%2F1742-2094-5-2" rel="nofollow">10.1186/1742-2094-5-2</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/18184433" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/18184433">PMID 18184433</a><span class="printonly">. <a href="http://www.jneuroinflammation.com/content/5/1/2" class="external free" title="http://www.jneuroinflammation.com/content/5/1/2" rel="nofollow">http://www.jneuroinflammation.com/content/5/1/2</a></span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Rapid+cognitive+improvement+in+Alzheimer%27s+disease+following+perispinal+etanercept+administration&amp;rft.jtitle=J.+Neuroinflammation&amp;rft.aulast=Tobinick+Edward+L.%2C+Gross+H.&amp;rft.au=Tobinick+Edward+L.%2C+Gross+H.&amp;rft.date=2008&amp;rft.volume=5&amp;rft.issue=2&amp;rft.pages=2&amp;rft_id=info:doi/10.1186%2F1742-2094-5-2&amp;rft_id=info:pmid/18184433&amp;rft_id=http%3A%2F%2Fwww.jneuroinflammation.com%2Fcontent%2F5%2F1%2F2&amp;rfr_id=info:sid/en.wikipedia.org:Etanercept"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-17"><b><a href="#cite_ref-17" title="">^</a></b> <a href="http://www.newscientist.com/channel/health/mental-health/mg19926681.600-is-miracle-alzheimers-cure-too-good-to-be-true.html" class="external free" title="http://www.newscientist.com/channel/health/mental-health/mg19926681.600-is-miracle-alzheimers-cure-too-good-to-be-true.html" rel="nofollow">http://www.newscientist.com/channel/health/mental-health/mg19926681.600-is-miracle-alzheimers-cure-too-good-to-be-true.html</a></li>
</ol>
</div>
<p><a name="External_links" id="External_links"></a></p>
<h2><span class="editsection">[<a href="/w/index.php?title=Etanercept&amp;action=edit&amp;section=11" title="Edit section: External links">edit</a>]</span> <span class="mw-headline">External links</span></h2>
<ul>
<li><a href="http://www.enbrel.com/" class="external text" title="http://www.enbrel.com/" rel="nofollow">Amgen/Wyeth Enbrel site</a></li>
<li><a href="http://www.123wise.net/enbrel.pdf" class="external text" title="http://www.123wise.net/enbrel.pdf" rel="nofollow">A case study on the development of Enbrel until Immunex's acquisition by Amgen</a></li>
</ul>
<table class="navbox" cellspacing="0" style=";">
<tr>
<td style="padding:2px;">
<table cellspacing="0" class="nowraplinks collapsible autocollapse" style="width:100%;background:transparent;color:inherit;;">
<tr>
<th style=";" colspan="2" class="navbox-title">
<div style="float:left; width:6em;text-align:left;">
<div class="noprint plainlinksneverexpand navbar" style="background:none; padding:0; font-weight:normal;;;border:none;; font-size:xx-small;"><a href="/wiki/Template:Immunosuppressants" title="Template:Immunosuppressants"><span title="View this template" style=";;border:none;">v</span></a>&#160;<span style="font-size:80%;">•</span>&#160;<a href="/w/index.php?title=Template_talk:Immunosuppressants&amp;action=edit&amp;redlink=1" class="new" title="Template talk:Immunosuppressants (page does not exist)"><span title="Discussion about this template" style=";;border:none;">d</span></a>&#160;<span style="font-size:80%;">•</span>&#160;<a href="http://en.wikipedia.org/w/index.php?title=Template:Immunosuppressants&amp;action=edit" class="external text" title="http://en.wikipedia.org/w/index.php?title=Template:Immunosuppressants&amp;action=edit" rel="nofollow"><span title="Edit this template" style=";;border:none;;">e</span></a></div>
</div>
<span style="font-size:110%;"><a href="/wiki/Immunomodulator" title="Immunomodulator">Immunomodulators</a>: <a href="/wiki/Immunosuppressive_drug" title="Immunosuppressive drug">Immunosuppressive drugs</a>&#160;/ <a href="/wiki/Immunosuppressant" title="Immunosuppressant">Immunosuppressants</a> (<a href="/wiki/ATC_code_L04" title="ATC code L04">L04</a>)</span></th>
</tr>
<tr style="height:2px;">
<td></td>
</tr>
<tr>
<td class="navbox-group" style=";background-color: MistyRose;">Intracellular<br />
(signal initiation)</td>
<td style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-odd">
<div style="padding:0em 0.25em"></div>
<table cellspacing="0" class="nowraplinks navbox-subgroup" style="width:100%;;;;">
<tr>
<td class="navbox-group" style=";padding-left:0em;padding-right:0em;background-color: MistyRose;">
<div style="padding:0em 0.75em;"><a href="/wiki/Antimetabolite" title="Antimetabolite">Antimetabolites</a></div>
</td>
<td style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-odd">
<div style="padding:0em 0.25em"><i><a href="/wiki/Purine_synthesis_inhibitor" title="Purine synthesis inhibitor" class="mw-redirect">purine synthesis inhibitor</a>:</i> <a href="/wiki/Azathioprine" title="Azathioprine">Azathioprine</a><span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Mycophenolic_acid" title="Mycophenolic acid">Mycophenolic acid</a>
<p><i><a href="/wiki/Pyrimidine_synthesis_inhibitor" title="Pyrimidine synthesis inhibitor" class="mw-redirect">pyrimidine synthesis inhibitor</a>:</i> <a href="/wiki/Leflunomide" title="Leflunomide">Leflunomide</a><span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Teriflunomide" title="Teriflunomide">Teriflunomide</a></p>
<i><a href="/wiki/Antifolate" title="Antifolate">antifolate</a>:</i> <a href="/wiki/Methotrexate" title="Methotrexate">Methotrexate</a></div>
</td>
</tr>
<tr style="height:2px">
<td></td>
</tr>
<tr>
<td class="navbox-group" style=";padding-left:0em;padding-right:0em;background-color: MistyRose;">
<div style="padding:0em 0.75em;"><a href="/wiki/Macrolide" title="Macrolide">Macrolides</a>/<br />
other <a href="/wiki/Interleukin_2" title="Interleukin 2">IL-2</a> inhibitors</div>
</td>
<td style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-even">
<div style="padding:0em 0.25em"><i><a href="/wiki/FKBP" title="FKBP">FKBP</a>/<a href="/wiki/Cyclophilin" title="Cyclophilin">Cyclophilin</a>/<a href="/wiki/Calcineurin" title="Calcineurin">Calcineurin</a>:</i> <a href="/wiki/Tacrolimus" title="Tacrolimus">Tacrolimus</a><span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Ciclosporin" title="Ciclosporin">Ciclosporin</a><span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Pimecrolimus" title="Pimecrolimus">Pimecrolimus</a><br />
<a href="/wiki/Abetimus" title="Abetimus">Abetimus</a><span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Gusperimus" title="Gusperimus">Gusperimus</a></div>
</td>
</tr>
<tr style="height:2px">
<td></td>
</tr>
<tr>
<td class="navbox-group" style=";padding-left:0em;padding-right:0em;background-color: MistyRose;">
<div style="padding:0em 0.75em;"><a href="/wiki/Tumor_necrosis_factor-alpha" title="Tumor necrosis factor-alpha">TNF-α</a> inhibitor</div>
</td>
<td style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-odd">
<div style="padding:0em 0.25em"><a href="/wiki/Thalidomide" title="Thalidomide">Thalidomide</a><span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Lenalidomide" title="Lenalidomide">Lenalidomide</a></div>
</td>
</tr>
</table>
</td>
</tr>
<tr style="height:2px">
<td></td>
</tr>
<tr>
<td class="navbox-group" style=";background-color: MistyRose;">Intracellular<br />
(signal reception)</td>
<td style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-even">
<div style="padding:0em 0.25em"></div>
<table cellspacing="0" class="nowraplinks navbox-subgroup" style="width:100%;;;;">
<tr>
<td class="navbox-group" style=";padding-left:0em;padding-right:0em;background-color: MistyRose;">
<div style="padding:0em 0.75em;"><a href="/wiki/Interleukin_1_receptor_antagonist" title="Interleukin 1 receptor antagonist">IL-1 receptor antagonists</a></div>
</td>
<td style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-odd">
<div style="padding:0em 0.25em"><a href="/wiki/Anakinra" title="Anakinra">Anakinra</a></div>
</td>
</tr>
<tr style="height:2px">
<td></td>
</tr>
<tr>
<td class="navbox-group" style=";padding-left:0em;padding-right:0em;background-color: MistyRose;">
<div style="padding:0em 0.75em;"><a href="/wiki/Mammalian_target_of_rapamycin" title="Mammalian target of rapamycin">mTOR</a></div>
</td>
<td style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-even">
<div style="padding:0em 0.25em"><a href="/wiki/Sirolimus" title="Sirolimus">Sirolimus</a><span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Deforolimus" title="Deforolimus">Deforolimus</a><span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Everolimus" title="Everolimus">Everolimus</a><span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Temsirolimus" title="Temsirolimus">Temsirolimus</a><span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Zotarolimus" title="Zotarolimus">Zotarolimus</a></div>
</td>
</tr>
</table>
</td>
</tr>
<tr style="height:2px">
<td></td>
</tr>
<tr>
<td class="navbox-group" style=";background-color: MistyRose;">Extracellular</td>
<td style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-odd">
<div style="padding:0em 0.25em"></div>
<table cellspacing="0" class="nowraplinks navbox-subgroup" style="width:100%;;;;">
<tr>
<td class="navbox-group" style=";padding-left:0em;padding-right:0em;background-color: MistyRose;">
<div style="padding:0em 0.75em;"><a href="/wiki/Antibodies" title="Antibodies" class="mw-redirect">Antibodies</a></div>
</td>
<td style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-odd">
<div style="padding:0em 0.25em"></div>
<table cellspacing="0" class="nowraplinks navbox-subgroup" style="width:100%;;;;">
<tr>
<td class="navbox-group" style=";padding-left:0em;padding-right:0em;background-color: MistyRose;">
<div style="padding:0em 0.75em;"><a href="/wiki/Monoclonal_antibodies" title="Monoclonal antibodies">Monoclonal</a></div>
</td>
<td style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-odd">
<div style="padding:0em 0.25em"></div>
<table cellspacing="0" class="nowraplinks navbox-subgroup" style="width:100%;;;;">
<tr>
<td class="navbox-group" style=";padding-left:0em;padding-right:0em;background-color: MistyRose;">
<div style="padding:0em 0.75em;">Serum target<br />
(noncellular)</div>
</td>
<td style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-odd">
<div style="padding:0em 0.25em"><i><a href="/wiki/Complement_component_5" title="Complement component 5">Complement component 5</a></i> (<a href="/wiki/Eculizumab" title="Eculizumab">Eculizumab</a>)<span style="font-weight:bold;">&#160;·</span> <i><a href="/wiki/TNF_inhibitor" title="TNF inhibitor">TNFs</a></i> (<a href="/wiki/Infliximab" title="Infliximab">Infliximab</a>, <a href="/wiki/Adalimumab" title="Adalimumab">Adalimumab</a>, <a href="/wiki/Certolizumab_pegol" title="Certolizumab pegol">Certolizumab pegol</a>, <a href="/wiki/Afelimomab" title="Afelimomab">Afelimomab</a>, <a href="/wiki/Golimumab" title="Golimumab">Golimumab</a>)<span style="font-weight:bold;">&#160;·</span> <i><a href="/wiki/Interleukin_5" title="Interleukin 5">Interleukin 5</a></i> (<a href="/wiki/Mepolizumab" title="Mepolizumab">Mepolizumab</a>)<span style="font-weight:bold;">&#160;·</span> <i><a href="/wiki/Immunoglobulin_E" title="Immunoglobulin E">Immunoglobulin E</a></i> (<a href="/wiki/Omalizumab" title="Omalizumab">Omalizumab</a>) <span style="font-weight:bold;">&#160;·</span> <i>BAYX</i> (<a href="/wiki/Nerelimomab" title="Nerelimomab">Nerelimomab</a>)
<p><i><a href="/wiki/Interferon" title="Interferon">Interferon</a></i> (<a href="/wiki/Faralimomab" title="Faralimomab">Faralimomab</a>)</p>
<p><i><a href="/wiki/Interleukin-6" title="Interleukin-6" class="mw-redirect">IL-6</a></i> (<a href="/wiki/Elsilimomab" title="Elsilimomab">Elsilimomab</a>)</p>
<i><a href="/wiki/Interleukin_12" title="Interleukin 12">IL-12</a> and <a href="/wiki/Interleukin_13" title="Interleukin 13">IL-13</a></i> (<a href="/wiki/Ustekinumab" title="Ustekinumab">Ustekinumab</a>)</div>
</td>
</tr>
<tr style="height:2px">
<td></td>
</tr>
<tr>
<td class="navbox-group" style=";padding-left:0em;padding-right:0em;background-color: MistyRose;">
<div style="padding:0em 0.75em;">Cellular target</div>
</td>
<td style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-even">
<div style="padding:0em 0.25em"><i><a href="/wiki/CD3_(immunology)" title="CD3 (immunology)">CD3</a></i> (<a href="/wiki/OKT3" title="OKT3">Muromonab-CD3</a>, <a href="/wiki/Otelixizumab" title="Otelixizumab">Otelixizumab</a>, <a href="/wiki/Teplizumab" title="Teplizumab">Teplizumab</a>, <a href="/wiki/Visilizumab" title="Visilizumab">Visilizumab</a>)<span style="font-weight:bold;">&#160;·</span> <i><a href="/wiki/CD4" title="CD4">CD4</a></i> (<a href="/wiki/Clenoliximab" title="Clenoliximab">Clenoliximab</a>, <a href="/wiki/Keliximab" title="Keliximab">Keliximab</a>, <a href="/wiki/Zanolimumab" title="Zanolimumab">Zanolimumab</a>)<span style="font-weight:bold;">&#160;·</span> <i><a href="/wiki/CD11a" title="CD11a">CD11a</a></i> (<a href="/wiki/Efalizumab" title="Efalizumab">Efalizumab</a>)<span style="font-weight:bold;">&#160;·</span> <i><a href="/wiki/CD18" title="CD18">CD18</a></i> (<a href="/wiki/Erlizumab" title="Erlizumab">Erlizumab</a>)<span style="font-weight:bold;">&#160;·</span> <i><a href="/wiki/CD20" title="CD20">CD20</a></i> (<a href="/wiki/Afutuzumab" title="Afutuzumab">Afutuzumab</a>, <a href="/wiki/Ocrelizumab" title="Ocrelizumab">Ocrelizumab</a>, <a href="/wiki/Pascolizumab" title="Pascolizumab">Pascolizumab</a>)<span style="font-weight:bold;">&#160;·</span> <i><a href="/wiki/CD23" title="CD23">CD23</a></i> (<a href="/wiki/Lumiliximab" title="Lumiliximab">Lumiliximab</a>)<span style="font-weight:bold;">&#160;·</span> <i><a href="/wiki/CD40_(protein)" title="CD40 (protein)">CD40</a></i> (<a href="/wiki/Teneliximab" title="Teneliximab">Teneliximab</a>, <a href="/wiki/Toralizumab" title="Toralizumab">Toralizumab</a>)<span style="font-weight:bold;">&#160;·</span> <i><a href="/wiki/L-selectin" title="L-selectin">CD62L/L-selectin</a></i> (<a href="/wiki/Aselizumab" title="Aselizumab">Aselizumab</a>)<span style="font-weight:bold;">&#160;·</span> <i><a href="/wiki/CD80" title="CD80">CD80</a></i> (<a href="/wiki/Galiximab" title="Galiximab">Galiximab</a>)<span style="font-weight:bold;">&#160;·</span> <i><a href="/wiki/Basigin" title="Basigin">CD147/Basigin</a></i> (<a href="/wiki/Gavilimomab" title="Gavilimomab">Gavilimomab</a>, <a href="/w/index.php?title=Ziralimumab&amp;action=edit&amp;redlink=1" class="new" title="Ziralimumab (page does not exist)">Ziralimumab</a>)<span style="font-weight:bold;">&#160;·</span> <i><a href="/wiki/CD154" title="CD154">CD154</a></i> (<a href="/wiki/Ruplizumab" title="Ruplizumab">Ruplizumab</a>)<br />
<p><i>BLyS</i> (<a href="/wiki/Belimumab" title="Belimumab">Belimumab</a>) <span style="font-weight:bold;">&#160;·</span> <i><a href="/wiki/CTLA-4" title="CTLA-4">CTLA-4</a></i> (<a href="/wiki/Ipilimumab" title="Ipilimumab">Ipilimumab</a>, <a href="/wiki/Tremelimumab" title="Tremelimumab">Tremelimumab</a>)<span style="font-weight:bold;">&#160;·</span> <i><a href="/wiki/Chloramphenicol_acetyltransferase" title="Chloramphenicol acetyltransferase">CAT</a></i> (<a href="/wiki/Bertilimumab" title="Bertilimumab">Bertilimumab</a>, <a href="/wiki/Lerdelimumab" title="Lerdelimumab">Lerdelimumab</a>, <a href="/wiki/Metelimumab" title="Metelimumab">Metelimumab</a>)<span style="font-weight:bold;">&#160;·</span> <i><a href="/wiki/Integrin" title="Integrin">Integrin</a></i> (<a href="/wiki/Natalizumab" title="Natalizumab">Natalizumab</a>)<span style="font-weight:bold;">&#160;·</span> <i><a href="/wiki/Interleukin-6_receptor" title="Interleukin-6 receptor">Interleukin-6 receptor</a></i> (<a href="/wiki/Tocilizumab" title="Tocilizumab">Tocilizumab</a>)<span style="font-weight:bold;">&#160;·</span> <i><a href="/wiki/LFA-1" title="LFA-1" class="mw-redirect">LFA-1</a></i> (<a href="/wiki/Odulimomab" title="Odulimomab">Odulimomab</a>)</p>
<p><i><a href="/wiki/IL-2_receptor" title="IL-2 receptor">IL-2 receptor/CD25</a></i> (<a href="/wiki/Basiliximab" title="Basiliximab">Basiliximab</a>, <a href="/wiki/Daclizumab" title="Daclizumab">Daclizumab</a>, <a href="/wiki/Inolimomab" title="Inolimomab">Inolimomab</a>)</p>
<i><a href="/wiki/T-lymphocyte" title="T-lymphocyte" class="mw-redirect">T-lymphocyte</a></i> (<a href="/wiki/Zolimomab_aritox" title="Zolimomab aritox">Zolimomab aritox</a>)</div>
</td>
</tr>
<tr style="height:2px">
<td></td>
</tr>
<tr>
<td class="navbox-group" style=";padding-left:0em;padding-right:0em;background-color: MistyRose;">
<div style="padding:0em 0.75em;">Unsorted</div>
</td>
<td style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-odd">
<div style="padding:0em 0.25em"><a href="/wiki/Atlizumab" title="Atlizumab">Atlizumab</a>, <a href="/wiki/Atorolimumab" title="Atorolimumab">Atorolimumab</a>, <a href="/wiki/Cedelizumab" title="Cedelizumab">Cedelizumab</a>, <a href="/w/index.php?title=Dorlimomab_aritox&amp;action=edit&amp;redlink=1" class="new" title="Dorlimomab aritox (page does not exist)">Dorlimomab aritox</a>, <a href="/wiki/Dorlixizumab" title="Dorlixizumab">Dorlixizumab</a>, <a href="/wiki/Fontolizumab" title="Fontolizumab">Fontolizumab</a>, <a href="/wiki/Gantenerumab" title="Gantenerumab">Gantenerumab</a>, <a href="/wiki/Gomiliximab" title="Gomiliximab">Gomiliximab</a>, <a href="/wiki/Lebrilizumab" title="Lebrilizumab">Lebrilizumab</a>, <a href="/wiki/Maslimomab" title="Maslimomab">Maslimomab</a>, <a href="/wiki/Morolimumab" title="Morolimumab">Morolimumab</a>, <a href="/wiki/Pexelizumab" title="Pexelizumab">Pexelizumab</a>, <a href="/wiki/Reslizumab" title="Reslizumab">Reslizumab</a>, <a href="/wiki/Rovelizumab" title="Rovelizumab">Rovelizumab</a>, <a href="/wiki/Siplizumab" title="Siplizumab">Siplizumab</a>, <a href="/wiki/Talizumab" title="Talizumab">Talizumab</a>, <a href="/wiki/Telimomab_aritox" title="Telimomab aritox">Telimomab aritox</a>, <a href="/wiki/Vapaliximab" title="Vapaliximab">Vapaliximab</a>, <a href="/wiki/Vepalimomab" title="Vepalimomab">Vepalimomab</a></div>
</td>
</tr>
</table>
</td>
</tr>
<tr style="height:2px">
<td></td>
</tr>
<tr>
<td class="navbox-group" style=";padding-left:0em;padding-right:0em;background-color: MistyRose;">
<div style="padding:0em 0.75em;"><a href="/wiki/Polyclonal_antibodies" title="Polyclonal antibodies">Polyclonal</a></div>
</td>
<td style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-even">
<div style="padding:0em 0.25em"><a href="/wiki/Anti-thymocyte_globulin" title="Anti-thymocyte globulin">Anti-thymocyte globulin</a><span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Anti-lymphocyte_globulin" title="Anti-lymphocyte globulin">Anti-lymphocyte globulin</a></div>
</td>
</tr>
</table>
</td>
</tr>
<tr style="height:2px">
<td></td>
</tr>
<tr>
<td class="navbox-group" style=";padding-left:0em;padding-right:0em;background-color: MistyRose;">
<div style="padding:0em 0.75em;">-cept (<a href="/wiki/Fusion_protein" title="Fusion protein">Fusion protein</a>)</div>
</td>
<td style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-even">
<div style="padding:0em 0.25em"><i><a href="/wiki/CTLA-4" title="CTLA-4">CTLA-4</a></i> (<a href="/wiki/Abatacept" title="Abatacept">Abatacept</a>, <a href="/wiki/Belatacept" title="Belatacept">Belatacept</a>)<span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Aflibercept" title="Aflibercept">Aflibercept</a><span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Alefacept" title="Alefacept">Alefacept</a><span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Rilonacept" title="Rilonacept">Rilonacept</a><span style="font-weight:bold;">&#160;·</span> <a href="/wiki/TNF_inhibitor" title="TNF inhibitor">TNF inhibitor</a> (<strong class="selflink">Etanercept</strong>)</div>
</td>
</tr>
</table>
</td>
</tr>
</table>
</td>
</tr>
</table>


<!-- 
NewPP limit report
Preprocessor node count: 8451/1000000
Post-expand include size: 156428/2048000 bytes
Template argument size: 99063/2048000 bytes
Expensive parser function count: 4/500
-->

<!-- Saved in parser cache with key enwiki:pcache:idhash:732438-0!1!0!default!!en!2 and timestamp 20090404120231 -->
<div class="printfooter">
Retrieved from "<a href="http://en.wikipedia.org/wiki/Etanercept">http://en.wikipedia.org/wiki/Etanercept</a>"</div>
			<div id='catlinks' class='catlinks'><div id="mw-normal-catlinks"><a href="/wiki/Special:Categories" title="Special:Categories">Categories</a>:&#32;<span dir='ltr'><a href="/wiki/Category:TNF-alpha_inhibitors" title="Category:TNF-alpha inhibitors">TNF-alpha inhibitors</a></span> | <span dir='ltr'><a href="/wiki/Category:Amgen" title="Category:Amgen">Amgen</a></span> | <span dir='ltr'><a href="/wiki/Category:Recombinant_proteins" title="Category:Recombinant proteins">Recombinant proteins</a></span> | <span dir='ltr'><a href="/wiki/Category:Monoclonal_antibodies" title="Category:Monoclonal antibodies">Monoclonal antibodies</a></span> | <span dir='ltr'><a href="/wiki/Category:Immunosuppressants" title="Category:Immunosuppressants">Immunosuppressants</a></span></div><div id="mw-hidden-catlinks" class="mw-hidden-cats-hidden">Hidden categories:&#32;<span dir='ltr'><a href="/wiki/Category:All_pages_needing_cleanup" title="Category:All pages needing cleanup">All pages needing cleanup</a></span> | <span dir='ltr'><a href="/wiki/Category:Wikipedia_articles_needing_clarification_from_February_2009" title="Category:Wikipedia articles needing clarification from February 2009">Wikipedia articles needing clarification from February 2009</a></span> | <span dir='ltr'><a href="/wiki/Category:All_articles_with_unsourced_statements" title="Category:All articles with unsourced statements">All articles with unsourced statements</a></span> | <span dir='ltr'><a href="/wiki/Category:Articles_with_unsourced_statements_since_June_2007" title="Category:Articles with unsourced statements since June 2007">Articles with unsourced statements since June 2007</a></span> | <span dir='ltr'><a href="/wiki/Category:Articles_with_unsourced_statements_since_January_2009" title="Category:Articles with unsourced statements since January 2009">Articles with unsourced statements since January 2009</a></span></div></div>			<!-- end content -->
						<div class="visualClear"></div>
		</div>
	</div>
		</div>
		<div id="column-one">
	<div id="p-cactions" class="portlet">
		<h5>Views</h5>
		<div class="pBody">
			<ul>
	
				 <li id="ca-nstab-main" class="selected"><a href="/wiki/Etanercept" title="View the content page [c]" accesskey="c">Article</a></li>
				 <li id="ca-talk"><a href="/wiki/Talk:Etanercept" title="Discussion about the content page [t]" accesskey="t">Discussion</a></li>
				 <li id="ca-edit"><a href="/w/index.php?title=Etanercept&amp;action=edit" title="You can edit this page. &#10;Please use the preview button before saving. [e]" accesskey="e">Edit this page</a></li>
				 <li id="ca-history"><a href="/w/index.php?title=Etanercept&amp;action=history" title="Past versions of this page [h]" accesskey="h">History</a></li>			</ul>
		</div>
	</div>
	<div class="portlet" id="p-personal">
		<h5>Personal tools</h5>
		<div class="pBody">
			<ul>
				<li id="pt-login"><a href="/w/index.php?title=Special:UserLogin&amp;returnto=Etanercept" title="You are encouraged to log in; however, it is not mandatory. [o]" accesskey="o">Log in / create account</a></li>
			</ul>
		</div>
	</div>
	<div class="portlet" id="p-logo">
		<a style="background-image: url(http://upload.wikimedia.org/wikipedia/en/b/bc/Wiki.png);" href="/wiki/Main_Page" title="Visit the main page [z]" accesskey="z"></a>
	</div>
	<script type="text/javascript"> if (window.isMSIE55) fixalpha(); </script>
	<div class='generated-sidebar portlet' id='p-navigation'>
		<h5>Navigation</h5>
		<div class='pBody'>
			<ul>
				<li id="n-mainpage-description"><a href="/wiki/Main_Page" title="Visit the main page [z]" accesskey="z">Main page</a></li>
				<li id="n-contents"><a href="/wiki/Portal:Contents" title="Guides to browsing Wikipedia">Contents</a></li>
				<li id="n-featuredcontent"><a href="/wiki/Portal:Featured_content" title="Featured content — the best of Wikipedia">Featured content</a></li>
				<li id="n-currentevents"><a href="/wiki/Portal:Current_events" title="Find background information on current events">Current events</a></li>
				<li id="n-randompage"><a href="/wiki/Special:Random" title="Load a random article [x]" accesskey="x">Random article</a></li>
			</ul>
		</div>
	</div>
	<div id="p-search" class="portlet">
		<h5><label for="searchInput">Search</label></h5>
		<div id="searchBody" class="pBody">
			<form action="/w/index.php" id="searchform"><div>
				<input type='hidden' name="title" value="Special:Search"/>
				<input id="searchInput" name="search" type="text" title="Search Wikipedia [f]" accesskey="f" value="" />
				<input type='submit' name="go" class="searchButton" id="searchGoButton"	value="Go" title="Go to a page with this exact name if one exists" />&nbsp;
				<input type='submit' name="fulltext" class="searchButton" id="mw-searchButton" value="Search" title="Search Wikipedia for this text" />
			</div></form>
		</div>
	</div>
	<div class='generated-sidebar portlet' id='p-interaction'>
		<h5>Interaction</h5>
		<div class='pBody'>
			<ul>
				<li id="n-aboutsite"><a href="/wiki/Wikipedia:About" title="Find out about Wikipedia">About Wikipedia</a></li>
				<li id="n-portal"><a href="/wiki/Wikipedia:Community_portal" title="About the project, what you can do, where to find things">Community portal</a></li>
				<li id="n-recentchanges"><a href="/wiki/Special:RecentChanges" title="The list of recent changes in the wiki [r]" accesskey="r">Recent changes</a></li>
				<li id="n-contact"><a href="/wiki/Wikipedia:Contact_us" title="How to contact Wikipedia">Contact Wikipedia</a></li>
				<li id="n-sitesupport"><a href="http://wikimediafoundation.org/wiki/Donate" title="Support us">Donate to Wikipedia</a></li>
				<li id="n-help"><a href="/wiki/Help:Contents" title="Guidance on how to use and edit Wikipedia">Help</a></li>
			</ul>
		</div>
	</div>
	<div class="portlet" id="p-tb">
		<h5>Toolbox</h5>
		<div class="pBody">
			<ul>
				<li id="t-whatlinkshere"><a href="/wiki/Special:WhatLinksHere/Etanercept" title="List of all English Wikipedia pages containing links to this page [j]" accesskey="j">What links here</a></li>
				<li id="t-recentchangeslinked"><a href="/wiki/Special:RecentChangesLinked/Etanercept" title="Recent changes in pages linked from this page [k]" accesskey="k">Related changes</a></li>
<li id="t-upload"><a href="/wiki/Wikipedia:Upload" title="Upload files [u]" accesskey="u">Upload file</a></li>
<li id="t-specialpages"><a href="/wiki/Special:SpecialPages" title="List of all special pages [q]" accesskey="q">Special pages</a></li>
				<li id="t-print"><a href="/w/index.php?title=Etanercept&amp;printable=yes" rel="alternate" title="Printable version of this page [p]" accesskey="p">Printable version</a></li>				<li id="t-permalink"><a href="/w/index.php?title=Etanercept&amp;oldid=281260022" title="Permanent link to this version of the page">Permanent link</a></li><li id="t-cite"><a href="/w/index.php?title=Special:Cite&amp;page=Etanercept&amp;id=281260022">Cite this page</a></li>			</ul>
		</div>
	</div>
	<div id="p-lang" class="portlet">
		<h5>Languages</h5>
		<div class="pBody">
			<ul>
				<li class="interwiki-de"><a href="http://de.wikipedia.org/wiki/Etanercept">Deutsch</a></li>
				<li class="interwiki-fr"><a href="http://fr.wikipedia.org/wiki/%C3%89tanercept">Français</a></li>
				<li class="interwiki-nl"><a href="http://nl.wikipedia.org/wiki/Etanercept">Nederlands</a></li>
				<li class="interwiki-pl"><a href="http://pl.wikipedia.org/wiki/Etanercept">Polski</a></li>
				<li class="interwiki-pt"><a href="http://pt.wikipedia.org/wiki/Etanercepte">Português</a></li>
				<li class="interwiki-ru"><a href="http://ru.wikipedia.org/wiki/%D0%AD%D1%82%D0%B0%D0%BD%D0%B5%D1%80%D1%86%D0%B5%D0%BF%D1%82">Русский</a></li>
				<li class="interwiki-sv"><a href="http://sv.wikipedia.org/wiki/Enbrel">Svenska</a></li>
				<li class="interwiki-tr"><a href="http://tr.wikipedia.org/wiki/Etanercept">Türkçe</a></li>
			</ul>
		</div>
	</div>
		</div><!-- end of the left (by default at least) column -->
			<div class="visualClear"></div>
			<div id="footer">
				<div id="f-poweredbyico"><a href="http://www.mediawiki.org/"><img src="/skins-1.5/common/images/poweredby_mediawiki_88x31.png" alt="Powered by MediaWiki" /></a></div>
				<div id="f-copyrightico"><a href="http://wikimediafoundation.org/"><img src="/images/wikimedia-button.png" border="0" alt="Wikimedia Foundation"/></a></div>
			<ul id="f-list">
					<li id="lastmod"> This page was last modified on 2 April 2009, at 09:25.</li>
					<li id="copyright">All text is available under the terms of the <a class='internal' href="http://en.wikipedia.org/wiki/Wikipedia:Text_of_the_GNU_Free_Documentation_License" title="Wikipedia:Text of the GNU Free Documentation License">GNU Free Documentation License</a>. (See <b><a class='internal' href="http://en.wikipedia.org/wiki/Wikipedia:Copyrights" title="Wikipedia:Copyrights">Copyrights</a></b> for details.) <br /> Wikipedia&reg; is a registered trademark of the <a href="http://www.wikimediafoundation.org">Wikimedia Foundation, Inc.</a>, a U.S. registered <a class='internal' href="http://en.wikipedia.org/wiki/501%28c%29#501.28c.29.283.29" title="501(c)(3)">501(c)(3)</a> <a href="http://wikimediafoundation.org/wiki/Deductibility_of_donations">tax-deductible</a> <a class='internal' href="http://en.wikipedia.org/wiki/Non-profit_organization" title="Non-profit organization">nonprofit</a> <a href="http://en.wikipedia.org/wiki/Charitable_organization" title="Charitable organization">charity</a>.<br /></li>
					<li id="privacy"><a href="http://wikimediafoundation.org/wiki/Privacy_policy" title="wikimedia:Privacy policy">Privacy policy</a></li>
					<li id="about"><a href="/wiki/Wikipedia:About" title="Wikipedia:About">About Wikipedia</a></li>
					<li id="disclaimer"><a href="/wiki/Wikipedia:General_disclaimer" title="Wikipedia:General disclaimer">Disclaimers</a></li>
			</ul>
		</div>
</div>

		<script type="text/javascript">if (window.runOnloadHook) runOnloadHook();</script>
<!-- Served by srv211 in 0.043 secs. --></body></html>
